Manipulation of Interleukin-1β and Interleukin-18 Production by Yersinia pestis Effectors YopJ and YopM and Redundant Impact on Virulence

被引:31
作者
Ratner, Dmitry [1 ]
Orning, M. Pontus A. [1 ,2 ]
Starheim, Kristian K. [1 ,2 ]
Marty-Roix, Robyn [1 ]
Proulx, Megan K. [3 ]
Goguen, Jon D. [3 ]
Lien, Egil [1 ,2 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol,Program Innate Immun, Worcester, MA 01605 USA
[2] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway
[3] Univ Massachusetts, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; III SECRETION SYSTEM; INFLAMMASOME ACTIVATION; CELL-DEATH; EPITHELIAL-CELLS; BUBONIC PLAGUE; IMMUNE CELLS; CASPASE-1; INFECTION; EXPRESSION;
D O I
10.1074/jbc.M115.697698
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Innate immunity plays a central role in resolving infections by pathogens. Host survival during plague, caused by the Gram-negative bacterium Yersinia pestis, is favored by a robust early innate immune response initiated by IL-1 beta and IL-18. These cytokines are produced by a two-step mechanism involving NF-kappa B-mediated pro-cytokine production and inflammasome-driven maturation into bioactive inflammatory mediators. Because of the anti-microbial effects induced by IL-1 beta/IL-18, it may be desirable for pathogens to manipulate their production. Y. pestis type III secretion system effectors YopJ and YopM can interfere with different parts of this process. Both effectors have been reported to influence inflammasome caspase-1 activity; YopJ promotes caspase-8-dependent cell death and caspase-1 cleavage, whereas YopM inhibits caspase-1 activity via an incompletely understood mechanism. However, neither effector appears essential for full virulence in vivo. Here we report that the sum of influences by YopJ and YopM on IL-1 beta/IL-18 release is suppressive. In the absence of YopM, YopJ minimally affects caspase-1 cleavage but suppresses IL-1 beta, IL-18, and other cytokines and chemokines. Importantly, we find that Y. pestis containing combined deletions of YopJ and YopM induces elevated levels of IL-1 beta/IL-18 in vitro and in vivo and is significantly attenuated in a mouse model of bubonic plague. The reduced virulence of the YopJ-YopM mutant is dependent on the presence of IL-1 beta, IL-18, and caspase-1. Thus, we conclude that Y. pestis YopJ and YopM can both exert a tight control of host IL-1 beta/IL-18 production to benefit the bacteria, resulting in a redundant impact on virulence.
引用
收藏
页码:9894 / 9905
页数:12
相关论文
共 10 条
[1]   Evaluation of Caspase-1, Interleukin-1β, and Interleukin-18, in the Middle Ear Effusion in Children With Otitis Media With Effusion [J].
Liu, Shanshan ;
Guo, Lining ;
Chen, Min ;
Liu, Wei ;
Li, Yanhong ;
Wang, Xiaoxu ;
Li, Shilan ;
Zhang, Jie ;
Ni, Xin .
FRONTIERS IN PEDIATRICS, 2021, 9
[2]   The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells [J].
Piper, Sian C. ;
Ferguson, John ;
Kay, Linda ;
Parker, Lisa C. ;
Sabroe, Ian ;
Sleeman, Matthew A. ;
Briend, Emmanuel ;
Finch, Donna K. .
PLOS ONE, 2013, 8 (05)
[3]   Hirsutella sinensis mycelium suppresses interleukin-1β and interleukin-18 secretion by inhibiting both canonical and non-canonical inflammasomes [J].
Huang, Tsung-Teng ;
Chong, Kowit-Yu ;
Ojcius, David M. ;
Wu, Yi-Hui ;
Ko, Yun-Fei ;
Wu, Cheng-Yeu ;
Martel, Jan ;
Lu, Chia-Chen ;
Lai, Hsin-Chih ;
Young, John D. .
SCIENTIFIC REPORTS, 2013, 3
[4]   Molecularly Distinct NLRP3 Inducers Mediate Diverse Ratios of Interleukin-1β and Interleukin-18 from Human Monocytes [J].
Midtbo, Kristine ;
Eklund, Daniel ;
Sarndahl, Eva ;
Persson, Alexander .
MEDIATORS OF INFLAMMATION, 2020, 2020
[5]   Cross Talk Between Vascular Smooth Muscle Cells and Monocytes Through Interleukin-1β/Interleukin-18 Signaling Promotes Vein Graft Thickening [J].
Li, Ping ;
Li, Yu-lin ;
Li, Zhen-ya ;
Wu, Yi-na ;
Zhang, Cong-cong ;
A, Xi ;
Wang, Chun-xiao ;
Shi, Hong-tao ;
Hui, Mi-zhou ;
Xie, Bo ;
Ahmed, Mohammed ;
Du, Jie .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (09) :2001-2011
[6]   Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis [J].
Ridker, Paul M. ;
MacFadyen, Jean G. ;
Thuren, Tom ;
Libby, Peter .
EUROPEAN HEART JOURNAL, 2020, 41 (23) :2153-2163
[7]   Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis [J].
Lv, Sheng-yin ;
Wu, Qi ;
Liu, Jing-peng ;
Shao, Jiang ;
Wen, Li-li ;
Xue, Jin ;
Zhang, Xiang-sheng ;
Zhang, Qing-rong ;
Zhang, Xin .
WORLD NEUROSURGERY, 2018, 111 :E355-E366
[8]   The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1β and IL-18 Production [J].
Verma, Deepti ;
Sarndahl, Eva ;
Andersson, Henrik ;
Eriksson, Per ;
Fredrikson, Mats ;
Jonsson, Jan-Ingvar ;
Lerm, Maria ;
Soderkvist, Peter .
PLOS ONE, 2012, 7 (04)
[9]   A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague [J].
Spear, Abigail M. ;
Rana, Rohini R. ;
Jenner, Dominic C. ;
Flick-Smith, Helen C. ;
Oyston, Petra C. F. ;
Simpson, Peter ;
Matthews, Stephen J. ;
Byrne, Bernadette ;
Atkins, Helen S. .
MICROBIOLOGY-SGM, 2012, 158 :1593-1606
[10]   Differential production of interleukin-1 family cytokines (IL-1β, IL-18, IL-33 and IL-37) in patients with paracoccidioidomycosis: correlation with clinical form and antifungal therapy [J].
Rocha Moreira Alves, Andre Bueno ;
David, Murilo Amato ;
de Castro, Livia Furquim ;
da Silva, Rosiane Maria ;
Longhi, Larissa Nara Alegrini ;
de Souza Lima Blotta, Maria Heloisa ;
Mamoni, Ronei Luciano .
MEDICAL MYCOLOGY, 2018, 56 (03) :332-343